The 20 Best Stomach Cancer Doctors Near Me in Texas, US

Matthew Porembka is a Surgical Oncologist and a General Surgeon practicing medicine in Dallas, Texas. Dr. Porembka is rated as an Elite provider by MediFind in the treatment of Stomach Cancer. He is also highly rated in 27 other conditions, according to our data. His clinical expertise encompasses Stomach Cancer, Pancreatic Cancer, Gastroesophageal Junction Cancer, Pancreaticoduodenectomy, and Pancreatectomy.

Brian Badgwell is a General Surgeon practicing medicine in Houston, Texas. Dr. Badgwell is rated as an Elite provider by MediFind in the treatment of Stomach Cancer. He is also highly rated in 8 other conditions, according to our data. His clinical expertise encompasses Stomach Cancer, Gastroesophageal Junction Cancer, Esophageal Cancer, Gastrectomy, and Endoscopy.

Naruhiko Ikoma is a Surgical Oncologist practicing medicine in Houston, Texas. Dr. Ikoma is rated as an Elite provider by MediFind in the treatment of Stomach Cancer. He is also highly rated in 22 other conditions, according to our data. His clinical expertise encompasses Stomach Cancer, Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma, Gastrectomy, and Pancreaticoduodenectomy.

Mariela Blum is a Hematologist practicing medicine in Houston, Texas. Dr. Blum is rated as an Elite provider by MediFind in the treatment of Stomach Cancer. She is also highly rated in 5 other conditions, according to our data. Her clinical expertise encompasses Stomach Cancer, Familial Colorectal Cancer, Colorectal Cancer, Esophageal Cancer, and Pancreaticoduodenectomy.

Dr. Prakash Gatta's passion for advancing automation in surgery through robotics and digitally enhanced surgical care led him to a career in 2007 as a board-certified general surgeon with fellowship training in foregut/esophageal, gastrointestinal and minimally invasive surgery. Since that time, he has held numerous clinical faculty positions, including within the University of Cincinnati and the University of Washington, and served on several committees in exploration of new frontiers in minimally invasive GI surgery.For the American Foregut Society, Dr. Gatta acted as chair of the Robotics & Co-Chair of the Advocacy Committees. He has also served on the Digital Surgery, Artificial Intelligence and Robotics Committees for the Society of American Gastrointestinal and Endoscopic Surgeons. He is a Fellow of the American College of Surgeons as well as the co-inventor of a single port laparoscopic access tool used to promote less invasive GI surgeries.Dr. Gatta earned his medical degree in Mumbai, India, before setting down roots in the United States. He completed his general surgery residency at the University of Illinois College of Medicine at Peoria, where he served as chief resident of his class. He completed his esophageal, gastrointestinal and minimally invasive surgery fellowship at The Oregon Clinic in Portland under the mentorship of Dr. Lee Swanstrom an internationally recognized Esophageal Surgeon.Beyond the technological aspects of surgery, Dr. Gatta's areas of clinical focus include Oncology of the upper foregut (Esophageal & Gastric Cancer), the treatment of GERD, hiatal/paraesophageal hernia and Esophageal motility disorders such as Achalasia.When not with his patients, he provides charity care locally and internationally in India. In his free time he enjoys traveling with his family, cycling, painting and cheering on his Seattle Seahawks. Dr. Gatta is fluent in English, Hindi, Telugu, and Arabic. Dr. Gatta is rated as an Experienced provider by MediFind in the treatment of Stomach Cancer. He is also highly rated in 6 other conditions, according to our data. His clinical expertise encompasses Congenital Diaphragmatic Hernia, Hiatal Hernia, Hernia, Endoscopy, and Hernia Surgery.

Dr. Kimberly Washington is fellowship-trained in hepato-pancreato-biliary surgery with vast experience in the surgical and non-surgical treatment of liver, pancreas and biliary tract disorders. She uses a variety of techniques, including minimally invasive laparoscopy, endoscopy, ablation and robotic-assisted approaches, in the management of benign pancreatic masses, acute/chronic pancreatitis and pancreatic cysts. She is also trained in the management of hepatocellular carcinoma, cholangiocarcinoma and all liver metastatic diseases. Additionally, she treats benign diseases of the liver and biliary tract, including hepatic adenomas, liver hemangiomas, polycystic liver disease, simple and complex biliary stone disease, and bile duct injuries.Dr. Washington earned her medical degree and completed general surgery residency at the University of Tennessee in Memphis. She then served the Arlington, Texas community as a board-certified general surgeon from 2014 until 2020. In 2020, she returned to training in hepato-pancreato-biliary surgery fellowship at Oregon Health & Science University in Portland.In addition to her dedication to the management of surgical disease, Dr. Washington has also served on a global scale, caring for patients in India, Peru, Guatemala and Kenya. She has and continues to serve on numerous regional and national committees to advance the treatment of hepato-pancreato-biliary diseases. Dr Washington has published peer-reviewed works on areas of special interest, including multi-disciplinary management of colorectal liver metastasis with node-negative primary disease and surgical management of breast cancer liver metastasis, presenting many of these published works at national and international meetings. Through her role as a faculty member with the TCU Burnett School of Medicine, Dr. Washington was recognized in 2024 with the Gachman Endowed Faculty Excellence Award. She is a member of the American College of Surgeons, Americas Hepato-Pancreato-Biliary Association, American Pancreatic Association, Association of Women Surgeons, International Hepato-Pancreato-Biliary Association, Society of Surgical Oncology and Society for Surgery of the Alimentary Tract. Dr. Washington is rated as an Experienced provider by MediFind in the treatment of Stomach Cancer. She is also highly rated in 15 other conditions, according to our data. Her clinical expertise encompasses Pancreatic Cancer, Familial Pancreatic Cancer, Pancreatic Pseudocyst, Pancreatectomy, and Liver Embolization.

Dr. Winston Chan is a double board-certified General Surgeon and Colon and Rectal Surgeon with additional certification and training in the use of the Da Vinci Xi robotic system for minimally invasive surgeries. He is an accomplished surgeon with extensive experience in both university-based teaching and clinical robotics proctoring.Dr. Chan earned his medical degree from the University of Cincinnati College of Medicine. He completed his general surgery residency at The University of Texas Health Science Center at Houston and his colon and rectal surgery fellowship at Baylor University Medical Center in Dallas. Dr. Chan's passion lies in using the latest advanced medical technology, such as robotics and laparoscopy, in combination with his own surgical dexterity to treat complex diseases through small incisions to promote patient comfort and outcomes. His surgical expertise includes treatment of gallbladder disease, hernias, colorectal cancer, diverticulitis and inflammatory bowel disease, anorectal disease, reflux disorders, and soft tissue conditions. Outside of work, he enjoys snowboarding, scuba diving, traveling and spending time with family.Dr. Chan is a member of the American College of Surgeons, American Society of Colon and Rectal Surgeons, and Tarrant County Medical Society. He speaks English and Mandarin. Dr. Chan is rated as an Experienced provider by MediFind in the treatment of Stomach Cancer. He is also highly rated in 29 other conditions, according to our data. His clinical expertise encompasses Ogilvie Syndrome, Retroperitoneal Inflammation, Gallbladder Disease, Bladder Reconstruction, and Endoscopy.

Aravind Sanjeevaiah, MD is board-certified and fellowship training in Hematology and Oncology. After his fellowship training, he spent 3 years practicing in Anchorage, Alaska where he treated many patients with gastrointestinal cancers. His patients in Alaska presented him with unique clinical, social, and logistical challenges, which motivated him to cultivate an interest in GI oncology. He brought this interest in GI oncology to his previous practice where he ran clinical trials, trained medical students, residents, and fellows, and performed research in addition to treating patients with GI cancers. Dr. Sanjeevaiah is married to a fellow physician and has 3 children. In his spare time, he enjoys running, hiking, and spending time with his family at the beach. Dr. Sanjeevaiah is rated as a Distinguished provider by MediFind in the treatment of Stomach Cancer. He is also highly rated in 36 other conditions, according to our data. His clinical expertise encompasses Colorectal Cancer, Stomach Cancer, Neuroendocrine Tumor, and Pancreatic Cancer. Dr. Sanjeevaiah is board certified in Medical Oncology- American Board Of Internal Med/Medical Oncology, Hematology- American Board Of Internal Med/Hematology, Internal Medicine- American Board Of Internal Med, Internal Medicine- American Board Of Internal Medicine, Medical Oncology- American Board Of Internal Medicine, and Hematology- American Board Of Internal Medicine.

Dhiresh Jeyarajah is a General Surgeon practicing medicine in Richardson, Texas. Dr. Jeyarajah is rated as a Distinguished provider by MediFind in the treatment of Stomach Cancer. He is also highly rated in 63 other conditions, according to our data. His clinical expertise encompasses Hiatal Hernia, Hernia, Pancreatic Cancer, Pancreaticoduodenectomy, and Pancreatectomy. Dr. Jeyarajah is board certified in - American Board Of Surgery/General Surgery, General Surgery- American Board Of Surgery/General Surgery, and General Surgery- American Board Of Surgery.

Jeffrey Lamont is a General Surgeon and a Surgical Oncologist practicing medicine in Plano, Texas. Dr. Lamont is rated as an Advanced provider by MediFind in the treatment of Stomach Cancer. He is also highly rated in 31 other conditions, according to our data. His clinical expertise encompasses Breast Cancer, Familial Pancreatic Cancer, Pancreatic Cancer, Pancreatectomy, and Small Bowel Resection. Dr. Lamont is board certified in General Surgery- American Board Of Surgery/General Surgery and General Surgery- American Board Of Surgery.

Dr. Kelly received his medical degree from the Royal College of Surgeons in Ireland in 1998. He completed his internship, residency and oncology fellowship from the Royal College of Physicians in Ireland in 2007. Dr. Kelly completed a second fellowship in medical oncology at the National Cancer Institute (NCI) in Bethesda MD from 2007–2009 and continued as a clinical researcher in thoracic oncology at the NCI until moving to Johns Hopkins in 2011. At Johns Hopkins, Dr. Kelly was the director of the gastroesophageal cancer therapeutics program and also served as the director of global oncology for Johns Hopkins International. Dr. Kelly was recruited as the Director of Oncology for the Charles A. Sammons Cancer Center and the Chief of Oncology for the North Texas Division of the BSWH system in 2018. Dr. Kelly performs translational and clinical research encompassing the discovery and the development of new targeted and immunotherapeutic approaches in the prevention and treatment of gastroesophageal cancer and lung cancer and he is the International principal investigator on a number of global phase II/III clinical trials in these disease areas. In addition he is leading efforts nationally and internationally to design quality metrics for solid tumors and implementing value-based algorithms to help bend the cost curve in the United States. At the Charles A. Sammons Cancer Center he also helps to co-lead the Innovative Clinical Trials Center which investigates novel therapeutics across a range of tumor types. He serves as the co-chair of the International Association for the Study of Lung Cancer (IASLC) and the American Society of Clinical Oncology (ASCO) taskforce working to improve the quality of care received by lung cancer patients worldwide. He is an active member of ASCO and the Eastern Cooperative Oncology group. He is a founding member of the International Quality Oncology Taskforce in ASCO and serves on the ASCO measures taskforce, the clinical practice committee and the lung cancer quality taskforce. He has authored and co-authored over 150 peer-reviewed publications, abstracts and book chapters, and contributed his work to many prominent healthcare journals. Dr. Kelly’s leadership of oncology services spans Baylor Scott & White’s footprint in the Dallas-Fort Worth area, which includes Baylor University Medical Center—the System’s North Texas flagship hospital and one of the largest cancer hospitals in the nation—as well as a network of 11 Baylor Charles A. Sammons Cancer Centers throughout Texas. Publications. Dr. Kelly is rated as an Advanced provider by MediFind in the treatment of Stomach Cancer. He is also highly rated in 9 other conditions, according to our data. His clinical expertise encompasses Esophageal Cancer, Gastroesophageal Junction Cancer, Non-Small Cell Lung Cancer (NSCLC), Pancreaticoduodenectomy, and Tissue Biopsy. Dr. Kelly is board certified in Internal Medicine- American Board Of Internal Med, Internal Medicine- American Board Of Internal Med/Medical Oncology, - American Board Of Internal Med, - American Board Of Internal Med/Medical Oncology, Internal Medicine- American Board Of Internal Medicine, and Medical Oncology- American Board Of Internal Medicine.

David Smith is a Surgical Oncologist practicing medicine in Tyler, Texas. Dr. Smith is rated as an Advanced provider by MediFind in the treatment of Stomach Cancer. He is also highly rated in 25 other conditions, according to our data. His clinical expertise encompasses Pancreatic Cancer, Familial Pancreatic Cancer, Congenital Diaphragmatic Hernia, Small Bowel Resection, and Pancreatectomy. Dr. Smith is board certified in American Board Of Surgery.

Dr. Paulson is board certified in Medical Oncology and Internal Medicine. He serves as the co-director of the Gastrointestinal Research Program for The US Oncology Network, as well as the medical director for the Neuroendocrine Research and Treatment Center at Baylor Charles A. Sammons Cancer Center.Dr. Paulson is active in clinical research focused on neuroendocrine tumors, as well as cancers of the pancreas, liver, esophagus, stomach and colon. Dr. Paulson is rated as an Advanced provider by MediFind in the treatment of Stomach Cancer. He is also highly rated in 11 other conditions, according to our data. His clinical expertise encompasses Neuroendocrine Tumor, Pancreatic Cancer, Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET), Gastrostomy, and Endoscopy. Dr. Paulson is board certified in Medical Oncology- American Board Of Internal Med/Medical Oncology and Medical Oncology- American Board Of Internal Medicine.

Suhail Sharif is a General Surgeon practicing medicine in Fort Worth, Texas. Dr. Sharif is rated as an Advanced provider by MediFind in the treatment of Stomach Cancer. He is also highly rated in 20 other conditions, according to our data. His clinical expertise encompasses Familial Pancreatic Cancer, Pancreatic Cancer, Familial Colorectal Cancer, Splenectomy, and Pancreatectomy. Dr. Sharif is board certified in General Surgery- American Board Of Surgery/General Surgery and General Surgery- American Board Of Surgery.

Shanda Blackmon is a General Surgeon and a Surgical Oncologist practicing medicine in Houston, Texas. Dr. Blackmon is rated as an Advanced provider by MediFind in the treatment of Stomach Cancer. She is also highly rated in 13 other conditions, according to our data. Her clinical expertise encompasses Achalasia, Lung Cancer, Mesothelioma, Endoscopy, and Thymectomy. Dr. Blackmon is currently accepting new patients.

Dr. E. Ramsay Camp is Professor and Chief of the Division of Surgical Oncology in the Michael E. DeBakey Department of Surgery at Baylor College of Medicine.Dr. Camp’s clinical practice and expertise has focused on treating patients with complex tumors of the gastrointestinal system, including pancreatic and gastric malignancies, as well as sarcoma and melanoma. His professional interests include surgical oncology, pancreatic cancer, pancreaticobiliary malignancies, gastric cancer, sarcoma, melanoma, small bowel tumors, neuroendocrine tumors, gastrointestinal tumors, minimally invasive surgery, and hyperthermic intraperitoneal chemotherapy (HIPEC).Dr. Camp earned a B.A. in Chemistry from Davidson College and received his medical degree from the Medical University of South Carolina. He completed his general surgery training at Shand's Hospital at the University of Florida and finished a surgical oncology fellowship at the University of Texas M.D. Anderson Cancer Center.Following 12 years in practice at the Medical University of South Carolina, Dr. Camp joined the faculty of Baylor as the Chief of Surgical Oncology. He has an active, externally-funded research laboratory supported by a VA Merit Award, focusing on mechanisms of chemotherapy and radiation resistance in pancreatic and colorectal cancer.Dr. Camp is a fellow of the American College of Surgeons and a member of various oncology societies, including the American Surgical Association, the Southern Surgical Association, Society of Surgical Oncology, American Society of Clinical Oncology, American Association of Cancer Research, National Surgical Adjuvant Bowel Project, Southwest Oncology Group, and the American College of Surgeons Oncology Group.Professional Interests:Surgical oncologyPancreatic cancerPancreaticobiliary malignanciesGastric cancer and other gastric malignanciesSarcomaMelanomaSmall bowel tumorsNeuroendocrine tumorsGasrointestinal tumorsMinimally invasive surgeryHIPEC. Dr. Camp is rated as an Advanced provider by MediFind in the treatment of Stomach Cancer. He is also highly rated in 4 other conditions, according to our data. His clinical expertise encompasses Stomach Cancer, Melanoma, Familial Pancreatic Cancer, Pancreatectomy, and Small Bowel Resection. Dr. Camp is currently accepting new patients.

Sharad Jain is a Hematologist and an Oncologist practicing medicine in Denton, Texas. Dr. Jain is rated as an Advanced provider by MediFind in the treatment of Stomach Cancer. He is also highly rated in 14 other conditions, according to our data. His clinical expertise encompasses Paget Disease of the Breast, Anemia, Lung Cancer, and Pleuropulmonary Blastoma.

Dr. Mohamed Othman is the William T. Butler Endowed Chair for Distinguished Faculty and Professor of Medicine, Internal Medicine, Gastroenterology at Baylor College of Medicine. He is also Service Line Chief, Gastroenterology Section at Baylor St Luke's Medical Center; and Member of the Dan L Duncan Comprehensive Cancer Center at Baylor College of Medicine.Dr. Othman’s clinical interests include: endoscopic submucosal dissection, endoscopic mucosal resection, barrett's esophagus surveillance and ablation, chronic and acute pancreatitis, pancreatic cysts, pancreatic cancer screening for high-risk patients, endoscopic ultrasound, ERCP and cholangioscopy with laser; colorectal cancer screening & colonoscopy; per-oral endoscopic myotomy (POEM); gastric per-oral endoscopic myotomy for gastroparesis; and full thickness endoscopic resection.His professional skills cover tissue resection techniques such as ESD and EMR; management of chronic pancreatitis; endoscopic necrosectomy; EUS-assisted ERCP; per oral endoscopic myotomy; management of pancreatic cysts; and management of Barrett's Esophagus.Dr. Othman received his medical degree from the University of Mansoura School of Medicine in Mansoura, Egypt. He completed his residency in Internal Medicine at the University of New Mexico School of Medicine in Albuquerque, where he was also a Gastroenterology and Hepatology Fellow. He also completed a Fellowship in Advanced Endoscopy at the Mayo Clinic Jacksonville in Jacksonville, Florida.Dr. Othman holds certifications from the American Board of Internal Medicine and the American Board of Gastroenterology. He is a member of the American College of Gastroenterology, American Gastroenterology Association, American Society for Gastrointestinal Endoscopy, and American College of Physicians.Among his numerous awards, Dr. Othman received the 2014 Diversity Award from the American Society for Gastrointestinal Endoscopy. Dr. Othman is rated as an Advanced provider by MediFind in the treatment of Stomach Cancer. He is also highly rated in 23 other conditions, according to our data. His clinical expertise encompasses Exocrine Pancreatic Insufficiency, Colorectal Polyps, Achalasia, Endoscopy, and Colonoscopy. Dr. Othman is currently accepting new patients.

Hashem El-Serag, MD, is dedicated to delivering high-quality, compassionate care to Houston and nearby communities. Hashem El-Serag specializes in Gastroenterology and works at Baylor College of Medicine Gastroenterology. To make an appointment, please call (713) 798-2500. To review all accepted insurance carriers, please visit: https://www.stlukeshealth.org/patients-visitors/patients/billing-insurance/insurances-accepted. Dr. Serag is rated as an Advanced provider by MediFind in the treatment of Stomach Cancer. He is also highly rated in 19 other conditions, according to our data. His clinical expertise encompasses Barrett Esophagus, Liver Cancer, Hepatitis C, Endoscopy, and Colonoscopy. Dr. Serag is currently accepting new patients.

Scott Celinski is a Surgical Oncologist and a General Surgeon practicing medicine in Dallas, Texas. Dr. Celinski is rated as an Advanced provider by MediFind in the treatment of Stomach Cancer. He is also highly rated in 8 other conditions, according to our data. His clinical expertise encompasses Pancreatic Cancer, Familial Pancreatic Cancer, Cholangiocarcinoma (Bile Duct Cancer), Pancreatectomy, and Pancreaticoduodenectomy. Dr. Celinski is board certified in General Surgery- American Board Of Surgery/General Surgery, Surgical Critical Care- American Board Of Surgery/Surgical Critical Care, General Surgery- American Board Of Surgery, and Surgical Critical Care- American Board Of Surgery.